SAFEZONE Celebrates 13th Anniversary & Big Wins

SAFEZONE is celebrating its 13th anniversary and some of its big wins in healthcare solutions, including the latest in overcoming COVID.

Having commemorated 13 WONDERFULL, SUCCESSFULL years in business, SAFEZONE, Inc. now reaches a milestone for the VIRGINIA-based HEALTHCARE SOLUTIONS business, providing HEALTHCARE SOLUTIONS to COVID, fitness for the elderly, instructions for schools, educational institutions, corporations, and government agencies since 2007.

SAFEZONE, Inc. got its start in 2007 when founder Krishna Grandhi, one of the family members passed away because of Early COVID days and that made its CEO invent the company’s pandemic contact tracing solution with authentic health vitals.

One of the earliest challenges SAFEZONE faced was developing the technology of contact tracing with authentic information on health vitals when there were no other devices with temperature and oximeter readings in 2019.

Only SafeZone, Inc. customized the sensors in accordance with the demand for them.

While every business must face challenges, some like SAFEZONE are fortunate to enjoy truly successful wins and victories over these 13 blessed years.

Victory came when SAFEZONE was first to implement its Covid solution on Carnival Cruise Liners to protect and prevent passengers before they boarded the ships and also protecting students and teachers at many universities, UONV and schools in various states in the country.

Today dozens of Corporations use SAFEZONE device to stop the spread of the virus even after vaccinations, knowing prevention is better than consequence, so they’re also using the device to contact trace their employees in case of virus symptoms detection.

Brain F, VP of Sales at SAFEZONE, Inc. was also quoted when discussing another big win. “One of the high points of SAFEZONE’s history so far was moving into full health care solution via continuous monitoring of EKG and Blood Sugar using our FDA approved platform.”

SAFEZONE Inc’s Founder, Krishna Grandhi says, “We’re delighted to be celebrating our 13 Year Anniversary. I believe the secret to getting this far in business today is unique solution that doesn’t exist anywhere in the world.”

SAFEZONE Inc currently consists of 30 employees and has big plans for the upcoming year. One of its core objectives is to Help Communities with innovative solutions that do not exist in the world.

SAFEZONE thanks their friends, customers and all its partners for their well wishes on this happy occasion.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”